PAI1 Mouse Monoclonal Antibody [A9G8]
Usd: 350 Special Discount
Specification
Catalog# HA601152
PAI1 Mouse Monoclonal Antibody [A9G8]
-
WB
-
IHC-P
-
IF-Tissue
-
FC
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_HA601152_Europe.pdf
- No MSDS Found
Overview
Product Name
PAI1 Mouse Monoclonal Antibody [A9G8]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Synthetic peptide within human PAI1 aa 31-80 / 402.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P, IF-Tissue, FC
Target Molecular Weight
Predicted band size: 45 kDa
Positive Control
No heat NIH/3T3 cell lysate, no heat NIH/3T3 serum starved for 4 hours then treated with 10ng/mL TGF-β for 21 hours add 300ng/mL BFA for 18 hours cell lysate, NIH/3T3 cell lysate, NIH/3T3 serum starved for 4 hours then treated with 10ng/mL TGF-β for 21 hours add 300ng/mL BFA for 18 hours cell lysate, HUVEC cell lysate, mouse placenta tissue lysate, rat placenta tissue lysate, human breast carcinoma tissue, human placenta tissue, HepG2, NIH/3T3.
Conjugation
unconjugated
Clone Number
A9G8
RRID
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
| WB | IHC-P | IF-Tissue | FC | |
|---|---|---|---|---|
| Human |
|
|
|
|
| Mouse |
|
|
|
|
| Rat |
|
|
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000
-
IHC-P
-
1:5,000
-
IF-Tissue
-
1:1,000
-
FC
-
1:500-1:1,000
Target
Function
Plasminogen activator inhibitor-1 (PAI-1) also known as endothelial plasminogen activator inhibitor or serpin E1 is a protein that in humans is encoded by the SERPINE1 gene. Elevated PAI-1 is a risk factor for thrombosis and atherosclerosis. PAI-1 is a serine protease inhibitor (serpin) that functions as the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots). It is a serine protease inhibitor (serpin) protein (SERPINE1). The other PAI, plasminogen activator inhibitor-2 (PAI-2) is secreted by the placenta and only present in significant amounts during pregnancy. In addition, protease nexin acts as an inhibitor of tPA and urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. PAI-1's main function entails the inhibition of urokinase plasminogen activator (uPA), an enzyme responsible for the cleavage of plasminogen to form plasmin. Plasmin mediates the degradation of the extracellular matrix either by itself or in conjunction with matrix metalloproteinases. In this scenario, PAI-1 inhibits uPA via active site binding, preventing the formation of plasmin. Additional inhibition is mediated by PAI-1 binding to the uPA/uPA receptor complex, resulting in the latter's degradation. Thus, PAI can be said to inhibit the serine proteases tPA and uPA/urokinase, and hence is an inhibitor of fibrinolysis, the physiological process that degrades blood clots. In addition, PAI-1 inhibits the activity of matrix metalloproteinases, which play a crucial role in invasion of malignant cells through the basal lamina. PAI-1 is mainly produced by the endothelium (cells lining blood vessels), but is also secreted by other tissue types, such as adipose tissue.
Background References
1. Muñoz-Galván S et al. PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells. 2020 Apr
2. Cohen C et al. Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1. EMBO Mol Med. 2021 Nov
Subcellular Location
Secreted.
Synonyms
Clade E antibody
Endothelial plasminogen activator inhibitor antibody
Nexin antibody
Nexin plasminogen activator inhibitor type 1 antibody
PAI 1 antibody
PAI antibody
PAI-1 antibody
PAI1_HUMAN antibody
PLANH1 antibody
Plasminogen activator inhibitor 1 antibody
ExpandClade E antibody
Endothelial plasminogen activator inhibitor antibody
Nexin antibody
Nexin plasminogen activator inhibitor type 1 antibody
PAI 1 antibody
PAI antibody
PAI-1 antibody
PAI1_HUMAN antibody
PLANH1 antibody
Plasminogen activator inhibitor 1 antibody
Plasminogen activator inhibitor type 1 antibody
Serine (or cysteine) proteinase inhibitor antibody
Serine (or cysteine) proteinase inhibitor clade E (nexin plasminogen activator inhibitor type 1) member 1 antibody
Serine proteinase inhibitor clade E member 1 antibody
serpin antibody
Serpin E1 antibody
Serpin peptidase inhibitor clade E (nexin plasminogen activator inhibitor type 1) member 1 antibody
Serpin peptidase inhibitor clade E antibody
Serpine 1 antibody
SERPINE1 antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of PAI1 on different lysates with Mouse anti-PAI1 antibody (HA601152) at 1/1,000 dilution.
Lane 1: no heat NIH/3T3 cell lysate (20 µg/Lane)
Lane 2: no heat NIH/3T3 serum starved for 4 hours then treated with 10ng/mL TGF-β for 21 hours add 300ng/mL BFA for 18 hours cell lysate (20 µg/Lane)
Lane 3: NIH/3T3 cell lysate (20 µg/Lane)
Lane 4: NIH/3T3 serum starved for 4 hours then treated with 10ng/mL TGF-β for 21 hours add 300ng/mL BFA for 18 hours cell lysate (20 µg/Lane)
Lane 5: HUVEC cell lysate (20 µg/Lane)
Lane 6: Mouse placenta tissue lysate (40 µg/Lane)
Lane 7: Rat placenta tissue lysate (40 µg/Lane)
Notice: no heat means the lysate is not boiled.
Predicted band size: 45 kDa
Observed band size: 45/100 kDa
Exposure time: 10 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601152) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody (NBI02H) at 1:100,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with Mouse anti-PAI1 antibody (HA601152) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601152) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human placenta tissue with Mouse anti-PAI1 antibody (HA601152) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601152) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunofluorescence analysis of paraffin-embedded human placenta tissue labeling PAI1 with Mouse anti-PAI1 antibody (HA601152) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS, and then probed with the primary antibody (HA601152, green) at 1/1,000 dilution overnight at 4 ℃, washed with PBS.
Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. Nuclei were counterstained with DAPI (blue). -
Flow cytometric analysis of HepG2 cells labeling PAI1.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA601152, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of NIH/3T3 cells labeling PAI1.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA601152, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
DEC1 Deficiency Attenuates Breast Cancer-Induced Osteolytic Destruction by Suppression of Cancer-Associated Fibroblast Differentiation
Journal: Cancer Medicine
DOI: 10.1002/cam4.71940
IF: 3.5
Application: WB
Reactivity: Mouse
Publish date: 2026 May
-
Paeoniflorin alleviates nephrolithiasis by targeting serpine1 and inhibiting the NF-κB signaling pathway
Journal: Urolithiasis
DOI: 10.1007/s00240-026-01963-w
IF: 2.2
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Mar
-
Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis
Journal: Journal For Immunotherapy Of Cancer
DOI: 10.1136/jitc-2025-011997
IF: 10.6
Application: mIF
Reactivity: Mouse
Publish date: 2026 Jan
-
Thrombin-mediated increased permeability of blood-brain barrier in diquat poisoning: Mechanistic insights and potential therapeutic targets
Journal: Ecotoxicology And Environmental Safety
DOI: 10.1016/j.ecoenv.2026.120087
IF: 6.1
Application: IF-tissue
Reactivity: Rat
Publish date: 2026 Apr
-
An Injectable Hydrogel Enabling Photo-Temporal Modulation of Asymmetric Adhesion for Tissue Fixation and Prevention of Postoperative Peritoneal Adhesion
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202516756
IF: 19
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Nov
-
Multi-omics and experimental analysis unveil the key components in Scutellaria baicalensis Georgi to alleviate hepatic fibrosis via regulating cPLA2-mediated arachidonic acid metabolism
Journal: Journal Of Translational Medicine
DOI:
IF: 6.1
Application: WB
Reactivity: Mouse
Publish date: 2024 Dec
Alternative Products
p53 Recombinant Mouse Monoclonal Antibody [6B5-R]
Application: WB,IF-Cell
Reactivity: Human,Mouse,Green monkey
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [JB42-26]
Application: WB,IHC-P,FC,IF-Cell,IF-Tissue,IP
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Mouse Monoclonal Antibody [6B2-R]
Application: WB,IF-Cell
Reactivity: Human,Green monkey
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [SY010-6]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [PD01-32]
Application: IHC-P
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [PSH03-95]
Application: WB,IF-Cell,IP
Reactivity: Mouse
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [SA39-07]
Application: WB,IF-Cell,ChIP
Reactivity: Human
Conjugate: unconjugated